跳至主要内容
临床试验/CTRI/2025/12/099472
CTRI/2025/12/099472尚未招募2 期

A CLINICAL STUDY ON THE EFFICACY OF CHITRAKA KSHARA PRATISARANA KARAVIRADHYA MARSHA NASYA AND KSHARA GUTIKA IN NASA ARSHA WITH SPECIAL REFERENCE TO NASAL POLYPOSIS A SINGLE ARM STUDY

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2026年8月18日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
35
试验地点
1

研究概览

简要总结

This single-arm clinical study evaluates an integrated Ayurvedic protocol for Nasal Polyposis correlated with Nasa Arsha in Ayurveda It assesses the efficacy of Chitraka Kshara Pratisarana Karviradhya Taila Marsha Nasya and oral Kshara Gutika given along with conservative treatment over 21 days with followup for 2 months The aim is to offer a cost effective minimally invasive alternative to conventional surgery and systemic drugs targeting both local polyp reduction and associated chronic rhinosinusitis with a focus on lowering recurrence and improving patient satisfaction

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • All diagnosed patients of Nasal Polyps having sign and symptoms of Nasa Arsha like Atyadhik pratishyaya, Kshyavahu, Krichho swasa-uchwasa, Putinasya, Anunasika, etc.
  • Patients aged between 16-60 years.
  • Patients with associated conditions, such as Chronic rhinosinusitis with Nasal Polyposis (CRSwNP).
  • Patients not currently on systemic corticosteroids or immunotherapy in the last 4 weeks.
  • Patients who provide informed consent for the study.
  • Able to comply with follow-ups and study protocols.

排除标准

  • Patient having Sinonasal malignancies (e.g., squamous cell carcinoma, adenocarcinoma), Olfactory neuroblastoma.
  • Patients who have undergone recent nasal surgery within a span of one month.
  • Patient using systemic corticosteroids.
  • Patients with uncontrolled comorbidities like Hypertension , Diabetes, Bronchial Asthma etc.
  • Patient unfit for Nasya and Kshara Pratisarana.
  • Patient who has been already in any kind of experimental drug study.
  • Patients with cognitive impairment, non-compliance, or inability to provide informed consent.
  • Systemic illness, acute URTI, fungal rhinosinusitis etc.

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Pradip Adhikari

National Institute of Ayurveda, Jaipur, Rajasthan

研究点 (1)

Loading locations...

相似试验